Home/Ulcers/Article Record
Peer-Reviewed Article July 17, 2011

The Human Gastric PathogenHelicobacter pyloriand Its Association with Gastric Cancer and Ulcer Disease

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Ulcers
Publisher: Hindawi Publishing Corporation • Egypt • 2090-1526
DOI: https://doi.org/10.1155/2011/340157

Abstract

With the momentous discovery in the 1980's that a bacterium,Helicobacter pylori, can cause peptic ulcer disease and gastric cancer, antibiotic therapies and prophylactic measures have been successful, only in part, in reducing the global burden of these diseases. To date, ~700,000 deaths worldwide are still attributable annually to gastric cancer alone. Here, we reviewH. pylori's contribution to the epidemiology and histopathology of both gastric cancer and peptic ulcer disease. Furthermore, we examine the host-pathogen relationship andH. pyloribiology in context of these diseases, focusing on strain differences, virulence factors (CagA and VacA), immune activation and the challenges posed by resistance to existing therapies. We consider also the important role of host-genetic variants, for example, in inflammatory response genes, in determining infection outcome and the role ofH. pyloriin other pathologies—some accepted, for example, MALT lymphoma, and others more controversial, for example, idiopathic thrombocytic purpura. More recently, intriguing suggestions thatH. pylorihas protective effects in GERD and autoimmune diseases, such as asthma, have gained momentum. Therefore, we consider the basis for these suggestions and discuss the potential impact for future therapeutic rationales.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

113
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.